Company Filing History:
1 out of 3,840 
1 out of 1,200 
Years Active: 1984
Title: The Innovations of John T Dingle
Introduction
John T Dingle is a notable inventor based in Whittlesford, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions for treating inflammation. His work has implications for various medical conditions, showcasing the importance of research and development in healthcare.
Latest Patents
John T Dingle holds a patent for pharmaceutical compositions, specifically focusing on pharmaceutical liposome compositions that contain an anti-inflammatory steroid derivative with a lipophilic substituent, such as cortisol 21-hexadecanoate. This invention outlines a method for treating inflammation at a site involving an enclosed cavity, which is particularly relevant for conditions like rheumatic disease. The patent also specifies new steroid derivatives, including fluocinolone acetamide 21-hexadecanoate, highlighting the innovative nature of his work.
Career Highlights
Throughout his career, John T Dingle has worked with prominent organizations, including Imperial Chemical Industries Limited and the National Research Development Corporation. His experience in these companies has allowed him to develop and refine his inventions, contributing to advancements in pharmaceutical technology.
Collaborations
John T Dingle has collaborated with notable individuals in his field, including John L Gordon and Geraint Jones. These partnerships have likely enhanced his research and development efforts, leading to impactful innovations.
Conclusion
John T Dingle's contributions to pharmaceutical compositions demonstrate the vital role of inventors in advancing medical treatments. His innovative work continues to influence the field and improve patient care.